Baxter bone graft gets green light for spine surgery

Orthobiologics company Baxter has received FDA clearance July 9 for its Altapore Shape Bioactive Bone Graft for spine surgery, according to Biospace.

Advertisement

Three things to know:

1. Altapore Shape is designed to promote bone growth and facilitate spinal fusion.

2. The product is used as a standalone bone graft substitute or as an autograft extender to fill gaps in the skeletal system, including the posterolateral spine and extremities.

3. Altapore Shape’s porosity boosts cellular activity by providing more surface area for cells to travel across the bone graft.

More articles on biologics:
Setting spine practices up for success post-pandemic: 5 industry insights
UAMS begins data gathering initiative with spine patients
3 spine surgeons on the move in June

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Biologics

  • Atreon Orthopedics and RenovoDerm have merged, according to a May 19 news release. Together the companies will leverage a comprehensive…

  • Miach Orthopaedics named Jamal Rushdy as its new CEO, according to a May 11 news release. Mr. Rushdy replaces Patrick…

  • Xtant Medical launched the Trivium Shaped bone graft, part of the Trivium bone graft portfolio, according to a May 6…

Advertisement

Comments are closed.